Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia

[1]  Asim Khwaja,et al.  Acute myeloid leukaemia , 2016, Nature Reviews Disease Primers.

[2]  Rongxia Liao,et al.  Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia , 2013, Hematology.

[3]  Zunnan Huang,et al.  Long non-coding RNA: a new player in cancer , 2013, Journal of Hematology & Oncology.

[4]  Ying Liang,et al.  MicroRNA-376c inhibits cell proliferation and invasion in osteosarcoma by targeting to transforming growth factor-alpha. , 2013, DNA and cell biology.

[5]  I. Behrmann,et al.  MiRNA-29: a microRNA family with tumor-suppressing and immune-modulating properties. , 2013, Current molecular medicine.

[6]  L. Zhong,et al.  miR-29b suppresses CML cell proliferation and induces apoptosis via regulation of BCR/ABL1 protein. , 2013, Experimental cell research.

[7]  E. Rego,et al.  Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia , 2013, Experimental Hematology & Oncology.

[8]  Yumeng Sun,et al.  Diverse functions of miR-125 family in different cell contexts , 2013, Journal of Hematology & Oncology.

[9]  H. Ezelle,et al.  Regulation of human RNase-L by the miR-29 family reveals a novel oncogenic role in chronic myelogenous leukemia. , 2013, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[10]  B. Vundinti,et al.  MicroRNAs in hematological malignancies: a novel approach to targeted therapy , 2012, Hematology.

[11]  U. Testa,et al.  The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer , 2012, Journal of Hematology & Oncology.

[12]  Norma I Rodríguez-Malavé,et al.  MicroRNAs in B cell development and malignancy , 2012, Journal of Hematology & Oncology.

[13]  Li-Rong Chen,et al.  miR-29a and miR-142-3p downregulation and diagnostic implication in human acute myeloid leukemia , 2012, Molecular Biology Reports.

[14]  Norbert Gretz,et al.  miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes , 2011, J. Biomed. Informatics.

[15]  K. Ansel,et al.  MicroRNA-29 regulates T-box transcription factors and interferon-γ production in helper T cells. , 2011, Immunity.

[16]  Shaohua Chen,et al.  Change in expression pattern of TCR–CD3 complex in patients with multiple myeloma , 2011, Hematology.

[17]  H. Klamová,et al.  Expression patterns of microRNAs associated with CML phases and their disease related targets , 2011, Molecular Cancer.

[18]  D. Green,et al.  Apoptosis and oncogenesis: give and take in the BCL-2 family. , 2011, Current opinion in genetics & development.

[19]  Guido Marcucci,et al.  The prognostic and functional role of microRNAs in acute myeloid leukemia. , 2011, Blood.

[20]  Y. Pekarsky,et al.  Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression , 2010, Proceedings of the National Academy of Sciences.

[21]  Haifeng Zhao,et al.  MicroRNA and leukemia: tiny molecule, great function. , 2010, Critical reviews in oncology/hematology.

[22]  I. Behrmann,et al.  Signatures of microRNAs and selected microRNA target genes in human melanoma. , 2010, Cancer research.

[23]  Tint Lwin,et al.  microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. , 2010, Blood.

[24]  I. Weissman,et al.  microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia , 2010, The Journal of experimental medicine.

[25]  Zhaoyong Hu,et al.  Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury. , 2010, Cardiovascular research.

[26]  C. Croce,et al.  MicroRNA 29b functions in acute myeloid leukemia. , 2009, Blood.

[27]  J. Yun,et al.  Effects of MicroRNA‐29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma , 2009, Hepatology.

[28]  Edurne San José-Enériz,et al.  MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations , 2009, Molecular Cancer.

[29]  C. Bloomfield,et al.  MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. , 2009, Blood.

[30]  K. Zatloukal,et al.  miR‐29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis , 2009, EMBO reports.

[31]  Liu Hong,et al.  miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells , 2008, International journal of cancer.

[32]  Bob Löwenberg,et al.  MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. , 2008, Blood.

[33]  George A Calin,et al.  MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. , 2008, Blood.

[34]  Torsten Haferlach,et al.  Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin , 2008, Proceedings of the National Academy of Sciences.

[35]  G. Gores,et al.  mir-29 regulates Mcl-1 protein expression and apoptosis , 2007, Oncogene.

[36]  Andreas Hochhaus,et al.  Chronic myeloid leukaemia , 2007, The Lancet.

[37]  Jonathon Doran,et al.  Bio-informatic trends for the determination of miRNA-target interactions in mammals. , 2007, DNA and cell biology.

[38]  R. Stephens,et al.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. , 2006, Cancer cell.

[39]  Muller Fabbri,et al.  A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. , 2005, The New England journal of medicine.

[40]  John Calvin Reed,et al.  Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse. , 1998, Blood.

[41]  K. Franssila,et al.  BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. , 1997, Blood.

[42]  J. Magaud,et al.  High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. , 1993, Blood.

[43]  Y. Tsujimoto,et al.  Involvement of the bcl-2 gene in human follicular lymphoma. , 1985, Science.

[44]  I. Weissman,et al.  microRNA-29 a induces aberrant self-renewal capacity in hematopoietic progenitors , biased myeloid development , and acute myeloid leukemia , 2010 .

[45]  H. Kantarjian,et al.  Acute myeloid leukemia , 2018, Methods in Molecular Biology.

[46]  M. Fricová,et al.  High expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. , 2002, Neoplasma.

[47]  John Calvin Reed,et al.  bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. , 1993, Blood.